Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantitative Scientific Solutions, commonly known as QS-2, was a boutique scientific, engineering, and advanced analytics consulting firm based in Arlington, Virginia. The company provided technical consulting, data analytics, systems engineering, testing and evaluation, and digital solutions to federal and commercial clients. Its capabilities spanned biotechnology, artificial intelligence, aviation, autonomous systems, and program management, but it did not operate as a therapeutic biotech or drug-development company. In April 2022, QS-2 joined EY-Parthenon, and the business appears to have been absorbed into EY's consulting organization rather than continuing as an independent operating company. As a result, it is best characterized as an acquired consulting firm with some life-science-adjacent capabilities rather than a healthcare product company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantitative Scientific Solutions.